Core Insights - The medical beauty industry is undergoing transformation driven by technological advancements and evolving aesthetic perceptions, with non-surgical procedures becoming increasingly popular, particularly in anti-aging treatments [1] - Injection-based aesthetic procedures are gaining traction due to their effectiveness, short recovery times, and high repeat purchase rates, positioning the injection market as a new growth area within the medical beauty sector [1] Injection Aesthetic Concepts and Classification - Injection aesthetic procedures are minimally invasive treatments primarily categorized into hyaluronic acid, botulinum toxin, collagen, regenerative injectables, lipolytic injections, and thread lifting [2] - The market is dominated by hyaluronic acid and botulinum toxin, with botulinum toxin leading globally with 8.878 million treatments in 2023, followed by hyaluronic acid with 5.565 million treatments [2] Market Heat Analysis - The synthetic regeneration field is becoming an investment hotspot, with new materials and combinations expanding market boundaries [5] - By November 2024, 15 injectable products have been approved, primarily hyaluronic acid, with several others including polylactic acid and botulinum toxin [5] Hyaluronic Acid Development Status and Trends - Hyaluronic acid maintains its leading position, with a growth rate of 29.1% from 2022 to 2023, driven by diverse applications and combination treatments [11] - The industry faces challenges such as product homogenization and safety concerns, but innovation and differentiation present opportunities for growth [14][15] Botulinum Toxin Development Status and Trends - The botulinum toxin market is evolving towards a coexistence of natural and recombinant products, with recombinant botulinum toxin expected to penetrate the market due to its safety and customization potential [17] Regenerative Materials Development Status and Trends - Regenerative injectable products, particularly polylactic acid (PLA) and polycaprolactone (PCL), are gaining attention, with hydroxyapatite emerging as a potential market player [23] Collagen Development Status and Trends - The application of collagen in medical aesthetics is expanding, with various types being explored for their unique benefits, particularly types I and III for skin support and hydration [31] User Preferences and Trends - Users increasingly prioritize skin quality and overall facial harmony, with a shift towards personalized beauty standards [39] - The demand for skin improvement remains strong, with private care and hair transplant services emerging as new market opportunities [42] User Decision-Making and Experience - Safety and effectiveness are the primary concerns for users, with a growing emphasis on the qualifications of medical personnel and the quality of procedures over cost [45][60] - Users exhibit a cautious approach to decision-making, with a significant portion requiring thorough research before engaging in aesthetic procedures [47] Market Trends and Future Outlook - The injection aesthetic market is transitioning from simple filling procedures to a focus on long-lasting, precise, and personalized treatments, driven by technological advancements and consumer expectations [68] - Chinese companies are increasingly looking to international markets for growth, with a focus on regulatory compliance and brand recognition to overcome market entry barriers [71]

Core Insights - The medical beauty industry is undergoing transformation driven by technological advancements and evolving aesthetic perceptions, with non-surgical procedures becoming increasingly popular, particularly in anti-aging treatments [1] - Injection-based aesthetic procedures are gaining traction due to their effectiveness, short recovery times, and high repeat purchase rates, positioning the injection market as a new growth area within the medical beauty sector [1] Group 1: Injection Aesthetic Concepts and Classification - Injection aesthetic procedures are primarily categorized into hyaluronic acid, botulinum toxin, collagen, regenerative injectables, lipolytic injections, and thread lifting, with hyaluronic acid and botulinum toxin dominating the market [2] - In 2023, botulinum toxin treatments led globally with 8.878 million procedures, followed by hyaluronic acid with 5.565 million procedures, indicating a strong preference for these two categories [2] Group 2: Market Heat Analysis - The injection aesthetic market is experiencing rapid growth, driven by advancements in materials and techniques, with synthetic regenerative materials becoming a focal point for investment [6] - By 2024, approximately 60% of investments in injection materials are expected to be directed towards regenerative biological materials, highlighting a shift towards innovative solutions in the market [6] Group 3: Hyaluronic Acid Market Development - Hyaluronic acid maintains a strong market position, with a growth rate of 29.1% from 2022 to 2023, indicating its resilience and adaptability in the face of emerging competition [12] - The market faces challenges such as product homogenization and safety concerns, but opportunities exist for differentiation through innovation and new applications [14][15] Group 4: Botulinum Toxin Market Trends - The botulinum toxin market is evolving towards a dual existence of natural and recombinant products, with recombinant botulinum toxin expected to gain market share due to its safety and customization potential [17] - The market is characterized by intense competition, necessitating a focus on product differentiation and strategic positioning to navigate challenges [19] Group 5: Regenerative Materials Market Insights - The regenerative materials market is currently focused on polylactic acid (PLA) and polycaprolactone (PCL), with significant growth potential in the coming years [23] - New entrants are encouraged to explore innovative technologies and applications, particularly in areas like hydroxyapatite, which is gaining traction for its structural support in aesthetic procedures [27] Group 6: Collagen Market Trends - The collagen market is expanding with various types being explored for aesthetic applications, particularly types I and III, which are popular for their skin-supporting properties [31] - The market is expected to see increased competition as more types of collagen are developed and their applications are diversified [33] Group 7: User Preferences and Trends - Users are increasingly focused on skin quality and overall facial harmony, with a shift towards personalized aesthetic solutions [39][42] - Safety and effectiveness remain the top concerns for users, with a growing emphasis on the qualifications of medical professionals and the quality of procedures over cost [45][60] Group 8: Market Expansion and Internationalization - Chinese medical beauty companies are increasingly looking to international markets, with a focus on regulatory compliance and brand recognition to overcome challenges in foreign markets [70] - The injection aesthetic products are leading the charge in this internationalization effort, with significant investments in regions like Southeast Asia and the Middle East [70]

Core Insights - The aesthetic medicine industry is undergoing transformation driven by technological advancements and evolving aesthetic perceptions, with a focus on non-surgical procedures and anti-aging demands [1] - Injection-based aesthetic procedures are gaining popularity due to their effectiveness, short recovery times, and high repeat purchase rates, positioning them as a new growth area in the aesthetic market [1] Group 1: Injection Aesthetic Medicine Overview - Injection aesthetic procedures are primarily categorized into hyaluronic acid, botulinum toxin, collagen, regenerative injectables, lipolytic injections, and thread lifting, with hyaluronic acid and botulinum toxin dominating the market [2] - In 2023, botulinum toxin treatments ranked first globally with 8.878 million procedures, while hyaluronic acid ranked second with 5.565 million procedures [2] Group 2: Market Trends and Investment Opportunities - The synthetic regeneration field is becoming a hot investment area, with new materials and combinations expanding market boundaries, accounting for approximately 60% of total investment in injection materials [6] - The approval of 15 injectable products by regulatory authorities by November 2024 indicates a growing market, with hyaluronic acid remaining a staple despite recent investment trends [6] Group 3: Hyaluronic Acid Market Dynamics - Hyaluronic acid maintains a strong market position, with a growth rate of 29.1% from 2022 to 2023, indicating a "second growth curve" driven by diverse applications and combination therapies [12] - The industry faces challenges such as product homogenization and safety concerns, but innovation and differentiation strategies can provide entry opportunities [14][15] Group 4: Botulinum Toxin Market Insights - The botulinum toxin market is evolving towards a coexistence of natural and recombinant products, with recombinant botulinum toxin expected to penetrate the market due to its safety and customization potential [17] - Companies must carefully evaluate the cost-benefit ratio when entering the botulinum toxin market, as competition intensifies and regulatory environments remain challenging [19] Group 5: Regenerative Materials Market Trends - Regenerative materials like PLA and PCL are gaining traction, with a focus on products that stimulate collagen regeneration, leading to a rich variety of offerings in the aesthetic market [23] - New entrants should target potential markets like hydroxyapatite, which is rapidly gaining consumer awareness and market share [27] Group 6: Collagen Market Developments - The collagen market is expanding with various types being explored for aesthetic applications, particularly types I and III, which are popular for their skin-supporting properties [31] - The market for collagen injectables is expected to grow as regulatory approvals increase, although competition will intensify [33] Group 7: Consumer Preferences and Trends - Aesthetic medicine users prioritize skin quality and overall facial harmony, with a shift towards personalized beauty solutions and a growing interest in non-surgical procedures [39][42] - Safety and effectiveness remain the top concerns for consumers, with a notable decline in the importance of cost, reflecting a more discerning consumer base [45] Group 8: Market Entry and Competitive Strategies - Companies are encouraged to focus on material innovation, service customization, and strategic international expansion to capture market share in the evolving aesthetic landscape [70] - The global expansion of Chinese aesthetic medicine products is underway, with a focus on compliance and local market strategies to overcome regulatory challenges [70]

Investment Rating - The report rates the injection-based medical beauty industry as a new blue ocean market with significant growth potential [1]. Core Insights - The medical beauty industry is undergoing transformation driven by technological advancements and evolving aesthetic perceptions, with a focus on non-surgical procedures and natural results [1]. - The injection-based medical beauty market is experiencing rapid growth due to the increasing variety of procedures, high repurchase rates, and a market expansion that outpaces industry averages [1][5]. - The report highlights the emergence of new materials and innovations in traditional materials, which are enhancing the diversity of injection-based procedures [5][7]. Summary by Sections Injection-based Medical Beauty Concept and Classification - Injection-based medical beauty procedures are primarily categorized into hyaluronic acid, botulinum toxin, collagen, regenerative injectables, lipolytic injections, and thread lifting [2]. - According to ISAPS data, botulinum toxin leads globally with 8.878 million procedures, followed by hyaluronic acid with 5.565 million [2]. Market Heat Analysis - The synthetic regenerative materials are becoming investment hotspots, with significant funding directed towards companies in this sector [5]. - As of November 2024, 15 injectable products have received approval, primarily in the hyaluronic acid category [5]. Hyaluronic Acid Market Trends - Hyaluronic acid maintains a strong market position, with a growth rate of 29.1% from 2022 to 2023, indicating a "second growth curve" for the product [7]. Botulinum Toxin Market Trends - The market is expected to see a coexistence of natural and recombinant botulinum toxins, with recombinant products gaining traction due to their safety and customization potential [11]. Regenerative Materials Market Trends - The regenerative materials market is focusing on PLA and PCL, with hydroxyapatite emerging as a potential market leader [14]. Collagen Market Trends - The application of collagen in medical beauty is expanding, with a focus on types I and III for facial support and hydration [18]. User Preferences and Trends - The demand for skin improvement procedures is increasing, with a notable rise in interest in private care and hair transplant services [28][29]. - Users are becoming more discerning, prioritizing safety and effectiveness over cost, reflecting a shift in consumer behavior [31][34]. Injection-based Project Satisfaction and Repurchase Intent - Users express high satisfaction with injection-based procedures, particularly water light needles, which have the highest repurchase intent [41][42]. Market Expansion and Internationalization - Chinese companies are increasingly entering international markets, with a focus on hyaluronic acid and collagen products, while facing regulatory challenges [59].

注射类医美丨研究报告 核心摘要： 技术手段与审美认知共同引领医美行业变革。随着医美行业进入发展期，非手术项目选择逐渐丰富，"抗衰 老"成为消费者的核心诉求。注射类轻医美项目为精细化美容塑型提供技术支持，消费者在"变美"基础上更 加追求"自然"。随着新材料的不断出现、及传统材料的不断创新，注射类医美项目丰富度持续提升，满足多 元审美需求，加之其效果明显、恢复期短、可及性强，复购率不断上涨，案例数及市场规模呈现出超越行业 平均的增速。艾瑞认为，注射类医美市场将成为医美领域新蓝海。 注射类医美概念及分类 通过针剂注射实现微创美容，透明质酸和肉毒素二分天下 注射类医美项目是通过针剂注射方式实现微创美容效果的治疗手段，主要分为透明质酸类、肉毒素 类、胶原蛋白类、再生针剂类、溶脂针类和埋植线类。其中，医美注射类市场一直被透明质酸和肉 毒素二分天下，根据 ISAPS 数据， 2023 年全球注射类项目治疗次数排名中，肉毒素以 887.8 万例 居世界第一，玻尿酸以 556.5 万例居世界第二。此外，再生针剂、胶原蛋白针也是近年来的"明星 项目"，受到市场的狂热追捧。埋植线、溶脂针因技术不成熟、安全风险高等原因市场发展较为缓 ...

注射类医美丨研究报告 核心摘要： 技术手段与审美认知共同引领医美行业变革。随着医美行业进入发展期，非手术项目选择逐渐丰富，"抗衰 老"成为消费者的核心诉求。注射类轻医美项目为精细化美容塑型提供技术支持，消费者在"变美"基础上更 加追求"自然"。随着新材料的不断出现、及传统材料的不断创新，注射类医美项目丰富度持续提升，满足多 元审美需求，加之其效果明显、恢复期短、可及性强，复购率不断上涨，案例数及市场规模呈现出超越行业 平均的增速。艾瑞认为，注射类医美市场将成为医美领域新蓝海。 注射类医美概念及分类 通过针剂注射实现微创美容，透明质酸和肉毒素二分天下 注射类医美项目是通过针剂注射方式实现微创美容效果的治疗手段，主要分为透明质酸类、肉毒素 类、胶原蛋白类、再生针剂类、溶脂针类和埋植线类。其中，医美注射类市场一直被透明质酸和肉 毒素二分天下，根据 ISAPS 数据， 2023 年全球注射类项目治疗次数排名中，肉毒素以 887.8 万例 居世界第一，玻尿酸以 556.5 万例居世界第二。此外，再生针剂、胶原蛋白针也是近年来的"明星 项目"，受到市场的狂热追捧。埋植线、溶脂针因技术不成熟、安全风险高等原因市场发展较为缓 ...